| Patient | Jean-Jacques Rousseau |
|---|---|
| Date of birth | 1971-06-28 |
| Identifiers | MRN HR-EN003-SYN; SSN (made up) 000-03-2716 |
| Document date | 2026-11-01 |
| Author | Celestine Marchetti-Owusu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for beliefs of being plotted against, poor sleep, and difficulty passing urine. Concerns: Cannot pass urine freely: a thin stream, straining, burning, and the feeling of never emptying; fears the passage will one day close completely; dilates himself with urethral sounds every few days; Sleeps four hours a night and lies awake going over what his former friends are doing to his name; Wants to be believed and not called mad, to read his own records, and to decide for himself; has little trust in doctors. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 2026-03-24 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet by mouth each morning | One tablet each morning | Oral route | 2026-04-21 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth three times a day with food for up to seven days | One tablet three times a day with food | Oral route | 2026-06-09 to 2026-06-16 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Kidney, ureter, and bladder ultrasound: normal kidneys without hydronephrosis; bladder wall thickened to 6 mm with trabeculation; post-void residual 190 mL; prostate 24 mL | 2026-01-23 to 2026-01-23 | completed | S |
| Retrograde urethrogram: a 1.5 cm ring-like narrowing of the proximal bulbar urethra with a lumen of about 8 French; penile urethra normal; no false passage or diverticulum | 2026-01-29 to 2026-01-29 | completed | S |
| Voiding cystourethrogram: the bladder neck opens normally; the posterior urethra is dilated above the bulbar narrowing; no reflux; bladder trabeculation | 2026-01-29 to 2026-01-29 | completed | S |
| Flexible cystourethroscopy: meatus normal in position and size (no hypospadias); a pale, dense ring of scar in the proximal bulbar urethra that the 16 French scope could not pass; no tumor or stone seen below it | 2026-01-29 to 2026-01-29 | completed | S |
| Bulbar urethroplasty by excision and primary anastomosis, his informed choice: 1.5 cm of dense spongiofibrosis excised and the ends joined; 16 French urethral catheter left in place. Pathology: dense fibrosis of the corpus spongiosum without inflammation or malignancy | 2026-03-24 to 2026-03-24 | completed | S |
| Pericatheter retrograde urethrogram three weeks after urethroplasty: no leak at the anastomosis; catheter removed and he voided well | 2026-04-14 to 2026-04-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2019-04-08 | Tdap vaccine | completed | S |
| 2026-09-22 | Influenza vaccine, 2026-2027 season | completed | S |
| 2026-09-22 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 2026-09-22 | Pneumococcal conjugate vaccine PCV20 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Early childhood | Almost continual retention of urine in early childhood, which he attributed to a defect in the bladder | D (CLM-0003) |
| From 1748 | Urinary retention reported in his letters, and years of self-treatment with urethral bougies | D (CLM-0005, CLM-0004) |
| 1758 | Frequent retentions with a rupture (hernia), and a year of languor | D (CLM-0007) |
| 1761 | A probe broke in the urethra; he feared for his life | D (CLM-0005) |
| 1766 to 1767 | Beliefs that the man who arranged his stay in England was plotting against him, and that the servants were spying on him | D (CLM-0011) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died nine days after his birth; cause not recorded in the cited source | D (CLM-0002) |
| Concern | Status | Evidence |
|---|---|---|
| Cannot pass urine freely: a thin stream, straining, burning, and the feeling of never emptying; fears the passage will one day close completely; dilates himself with urethral sounds every few days | active | S |
| Sleeps four hours a night and lies awake going over what his former friends are doing to his name | active | S |
| Wants to be believed and not called mad, to read his own records, and to decide for himself; has little trust in doctors | active | S |
Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-07-14; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 on 2026-01-20; Total score [MoCA] 28 on 2026-01-20; Total score [AUDIT-C] 1 on 2026-09-22; Symptom score [AUASI] 5 on 2026-07-14; If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] 1 on 2026-07-14; Maximum Urine flow by Uroflowmetry 20.8 on 2026-07-14; US Urinary bladder Volume post void 20 on 2026-06-09; Leukocytes [#/area] in Urine sediment by Microscopy high power field 2 on 2026-03-10; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-01-20; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-03-10; Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 on 2026-01-20; Urea nitrogen [Mass/volume] in Serum or Plasma 17 on 2026-01-20; Creatinine [Mass/volume] in Serum or Plasma 0.99 on 2026-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 91 on 2026-07-14; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-07-14; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-01-20; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-01-20; Hemoglobin [Mass/volume] in Blood 14.4 on 2026-03-10; Leukocytes [#/volume] in Blood by Automated count 6.2 on 2026-01-20; Platelets [#/volume] in Blood by Automated count 238 on 2026-01-20; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-01-20; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 2026-01-20; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-07-14; Cholesterol [Mass/volume] in Serum or Plasma 201 on 2026-07-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 47 on 2026-07-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 126 on 2026-07-14; Triglyceride [Mass/volume] in Serum or Plasma 138 on 2026-07-14; Waist Circumference at umbilicus by Tape measure 93 on 2026-07-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-09-22 [S]
Strengths and supports: Supports: his long-term partner at home, his writing, and his daily walks among plants; two old correspondents he still trusts [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under way | resolved | confirmed | R46.5 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed. |
| Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy booked | resolved | confirmed | R33.9 | S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed. |
| Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefs | active | confirmed | F22 | S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered. |
| Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retention | active | confirmed | N35.812 | S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis. |
| Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urine | active | confirmed | K40.90 | S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state. |
| Acute low back strain after splitting firewood, without sciatica, red flags, or urinary retention (bladder scan 20 mL); resolved within three weeks | resolved | confirmed | S39.012A | S — Synthetic common injury; the wood-splitting echoes a documented habit (CLM-0020), but no back injury is documented. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-01-20 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 2026-01-20 | Total score [MoCA] | 28 | {score} | S | ||
| 2026-01-20 | Total score [AUDIT-C] | 1 | {score} | S | ||
| 2026-01-20 | Symptom score [AUASI] | 24 | {score} | S | ||
| 2026-01-20 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 5 | {score} | S | ||
| 2026-01-20 | Maximum Urine flow by Uroflowmetry | 6.2 | mL/s | A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL | Low | S |
| 2026-01-20 | US Urinary bladder Volume post void | 180 | mL | <=100 mL | High | S |
| 2026-01-20 | Leukocytes [#/area] in Urine sediment by Microscopy high power field | 3 | /[HPF] | <=5 /[HPF] | Normal | S |
| 2026-01-20 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-01-20 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 | mg/dL | 8-23 mg/dL | Normal | S |
| 2026-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-01-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 87 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-20 | Glucose [Mass/volume] in Serum or Plasma | 93 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-20 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-01-20 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | <=41 U/L | Normal | S |
| 2026-01-20 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-01-20 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 2026-01-20 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 2026-01-20 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-01-20 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-03-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 2026-03-10 | Symptom score [AUASI] | 22 | {score} | S | ||
| 2026-03-10 | US Urinary bladder Volume post void | 210 | mL | <=100 mL | High | S |
| 2026-03-10 | Leukocytes [#/area] in Urine sediment by Microscopy high power field | 2 | /[HPF] | <=5 /[HPF] | Normal | S |
| 2026-03-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-10 | Hemoglobin [Mass/volume] in Blood | 14.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-04-21 | Symptom score [AUASI] | 6 | {score} | S | ||
| 2026-04-21 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 2 | {score} | S | ||
| 2026-04-21 | Maximum Urine flow by Uroflowmetry | 21.5 | mL/s | A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL | Normal | S |
| 2026-04-21 | US Urinary bladder Volume post void | 25 | mL | <=100 mL | Normal | S |
| 2026-04-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-04-21 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 92 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-21 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-21 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 2026-04-21 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-04-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-04-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 122 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-04-21 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-04-21 | Waist Circumference at umbilicus by Tape measure | 92 | cm | Below 102 cm for men | Normal | S |
| 2026-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-07-14 | Symptom score [AUASI] | 5 | {score} | S | ||
| 2026-07-14 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 1 | {score} | S | ||
| 2026-07-14 | Maximum Urine flow by Uroflowmetry | 20.8 | mL/s | A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL | Normal | S |
| 2026-07-14 | US Urinary bladder Volume post void | 30 | mL | <=100 mL | Normal | S |
| 2026-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.99 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 91 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-14 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 2026-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 201 | mg/dL | <=199 mg/dL | High | S |
| 2026-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 126 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 138 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-07-14 | Waist Circumference at umbilicus by Tape measure | 93 | cm | Below 102 cm for men | Normal | S |
| 2026-06-09 | US Urinary bladder Volume post void | 20 | mL | <=100 mL | Normal | S |
| 2026-09-22 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-09-22 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-20 | Body height | 166 | cm | S |
| 2026-01-20 | Body weight | 63.8 | kg | S |
| 2026-01-20 | Body mass index (BMI) [Ratio] | 23.2 | kg/m2 | S |
| 2026-01-20 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-01-20 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-01-20 | Heart rate | 84 | /min | S |
| 2026-01-20 | Respiratory rate | 16 | /min | S |
| 2026-01-20 | Body temperature | 36.7 | Cel | S |
| 2026-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-02-03 | Body height | 166 | cm | S |
| 2026-02-03 | Body weight | 63.6 | kg | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 23.1 | kg/m2 | S |
| 2026-02-03 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-02-03 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-02-03 | Heart rate | 80 | /min | S |
| 2026-02-03 | Respiratory rate | 14 | /min | S |
| 2026-02-03 | Body temperature | 36.6 | Cel | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-03-10 | Body height | 166 | cm | S |
| 2026-03-10 | Body weight | 64 | kg | S |
| 2026-03-10 | Body mass index (BMI) [Ratio] | 23.2 | kg/m2 | S |
| 2026-03-10 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-03-10 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-03-10 | Heart rate | 78 | /min | S |
| 2026-03-10 | Respiratory rate | 14 | /min | S |
| 2026-03-10 | Body temperature | 36.6 | Cel | S |
| 2026-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-04-21 | Body height | 166 | cm | S |
| 2026-04-21 | Body weight | 63.2 | kg | S |
| 2026-04-21 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-04-21 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-04-21 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-04-21 | Heart rate | 74 | /min | S |
| 2026-04-21 | Respiratory rate | 14 | /min | S |
| 2026-04-21 | Body temperature | 36.7 | Cel | S |
| 2026-04-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-07-14 | Body height | 166 | cm | S |
| 2026-07-14 | Body weight | 64.4 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 23.4 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 72 | /min | S |
| 2026-07-14 | Respiratory rate | 14 | /min | S |
| 2026-07-14 | Body temperature | 36.6 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-06-09 | Body height | 166 | cm | S |
| 2026-06-09 | Body weight | 64 | kg | S |
| 2026-06-09 | Body mass index (BMI) [Ratio] | 23.2 | kg/m2 | S |
| 2026-06-09 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-06-09 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-06-09 | Heart rate | 86 | /min | S |
| 2026-06-09 | Respiratory rate | 16 | /min | S |
| 2026-06-09 | Body temperature | 36.7 | Cel | S |
| 2026-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-09-22 | Body height | 166 | cm | S |
| 2026-09-22 | Body weight | 64.6 | kg | S |
| 2026-09-22 | Body mass index (BMI) [Ratio] | 23.4 | kg/m2 | S |
| 2026-09-22 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-09-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-09-22 | Heart rate | 70 | /min | S |
| 2026-09-22 | Respiratory rate | 14 | /min | S |
| 2026-09-22 | Body temperature | 36.6 | Cel | S |
| 2026-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-01-20 | Primary care visit for beliefs of being plotted against, poor sleep, and difficulty passing urine | finished | S |
| 2026-02-03 | Psychiatry consultation and review of the urethral imaging and cystoscopy | finished | S |
| 2026-03-10 | Seven-week review of psychotherapy and safety, and preparation for urethroplasty | finished | S |
| 2026-04-21 | Review four weeks after urethroplasty; start of aripiprazole | finished | S |
| 2026-07-14 | Twelve-week aripiprazole and urethroplasty follow-up | finished | S |
| 2026-06-09 | Same-day sick visit for low back pain | finished | S |
| 2026-09-22 | Adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Engagement without confrontation: listen to his account in full, acknowledge his distress and the real conflicts in his life, neither argue with nor agree with the beliefs, and agree shared goals that matter to him (sleep, less distress, freedom to write, and his bladder); give him copies of his results and notes | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Look for medical, substance, and neurocognitive causes: neurological examination, MoCA, blood count, metabolic panel, calcium, TSH, and vitamin B12; review of medicines and alcohol; brain imaging only if the course or examination is atypical | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Psychiatry consultation to confirm the diagnosis and the differential, assess the risk of harm to himself and others, advise on an antipsychotic and on cognitive behavioral therapy for psychosis, and assess his capacity to consent to urethral surgery | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Structured suicide and violence risk assessment with a written safety plan and the 988 Suicide & Crisis Lifeline; no firearms in the home; risk reviewed at every visit; signs for urgent care written down with him | completed | GL-SUICIDE-2024 | S |
| Urology assessment: IPSS, uroflowmetry, bladder scan for post-void residual, urinalysis, and creatinine now, and kidney and bladder ultrasound this week; retrograde urethrogram, voiding cystourethrogram, and flexible cystoscopy by the urology team next week; stop self-dilation with urethral sounds (urethral rest) and come in the same day if he cannot pass urine | completed | GL-AUA-USD-2023 | S |
| Right inguinal hernia: watchful waiting while it is minimally symptomatic, with the warning signs of incarceration explained; reassess once the straining has been relieved | completed | GL-HERNIA-2018 | S |
| Sleep: fixed rising time, daylight walks, no writing about his enemies after 8 pm, and no sedating antihistamines or anticholinergic sleep aids, which can worsen urinary retention | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Cognitive behavioral therapy for psychosis with the clinic psychologist, about 16 weekly to fortnightly sessions, aimed at distress, worry, sleep, and checking and safety behaviors rather than at disproving the beliefs | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Antipsychotic offered by shared decision-making: aripiprazole 5 mg daily recommended, for its low anticholinergic, sedative, and metabolic effects; he declined it at the consultation and the offer stays open; no compulsory treatment while he remains safe | completed | GL-APA-SCZ-2020, GL-DSM5TR-2022 | S |
| Bulbar urethroplasty by excision and primary anastomosis, his choice after dilation, internal urethrotomy, and self-catheterization had been explained; urethral rest until surgery; capacity to consent confirmed; catheter for three weeks with a pericatheter urethrogram before removal; acetaminophen rather than opioids afterwards | completed | GL-AUA-USD-2023 | S |
| Aripiprazole 5 mg each morning, started at his request; weight at 4, 8, and 12 weeks then quarterly; blood pressure, fasting glucose or hemoglobin A1c, and lipids at baseline and 12 weeks then yearly; waist at baseline and yearly; akathisia check at each visit; AIMS at baseline and every 6 months | completed | GL-CMID-2026, GL-APA-SCZ-2020 | S |
| Surveillance after urethroplasty: symptoms and IPSS, uroflowmetry, and post-void residual at about 3, 6, and 12 months; urethroscopy or a urethrogram only if symptoms return or the flow falls | completed | GL-AUA-USD-2023 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Sleep at least six hours most nights | 2026-07-14 | completed | About six and a half hours most nights by twelve weeks on aripiprazole | S |
| Less distress and preoccupation from the beliefs, so that he can write each morning and walk without fear | 2026-07-14 | completed | Preoccupation down from most of the day to under an hour; writing most mornings; the beliefs persist with less conviction | S |
| Stay in care: keep visits and psychotherapy sessions, with no sudden break in treatment | 2026-12-15 | active | Kept every visit and fourteen of sixteen CBT sessions | S |
| Pass urine with a free stream without self-dilation: maximum flow above 15 mL/s and post-void residual below 100 mL within three months of surgery | 2026-07-14 | completed | Maximum flow 20.8 mL/s and residual 30 mL four months after urethroplasty; no sounds used since January | S |
| No harm to himself or anyone else; safety plan kept current | 2026-12-15 | active | No suicidal or violent thoughts at any visit; safety plan reviewed at each visit | S |
Structured synthetic safety assessment on 2026-01-20: current ideation absent, intent absent, plan absent. Outpatient care with a two-week follow-up. He has persecutory beliefs but no thoughts of suicide or of harming anyone, no plan to confront or act against the people he fears, no command hallucinations, and no access to firearms, so he does not need hospital care. Risk factors reviewed: a persecutory delusion, insomnia, social isolation, chronic pain on passing urine, male sex, and a past thought of suicide after a painful accident many years ago. Signs for urgent care were written down with him (thoughts of harming himself or anyone else, planning to confront someone, not sleeping at all for two nights, or a sudden urge to leave his home). A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit [S]